Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISE-HF
2019-002558-21Phase 2Unknown
- Sponsor
- Applied Therapeutics, Inc.
- Start
- Nov 2019
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in diabetic cardiomyopathy (DCM) and heart failure (HF) comparing AT-001 with Placebo (2 arms). Primary endpoint: Change in peak oxygen uptake. Status: unknown.
02
Drugs
ATT001
03
Conditions
diabetic cardiomyopathy (DCM)heart failure (HF)
Beyond the preview
Go deeper on 2019-002558-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002558-21.